On the same day the stockbroker for then-Georgia Congressman
Tom Price bought him up to $90,000 of stock in six pharmaceutical companies
last year, Price arranged to call a top U.S. health official, seeking to
scuttle a controversial rule that could have hurt the firms’ profits and driven
down their share prices, records obtained by ProPublica show.
Well, sometimes one's luck changes. Hopefully, Tom's will.
No comments:
Post a Comment